Banggulan, Roy .

HRN: 16-79-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/07/2024
06/08/2024
IVT
500 MG
1 Hr PTOR
Urolithiasis
Waiting Final Action 
06/07/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/07/2024
06/14/2024
IV
500mg
OD
S/P Open Partial Cystectomy; Cystolithotomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: